Mounjaro®
Starting from £179.99/mo
Start journey Learn moreBefore taking Wegovy, most people expect the hard part to be the injections. It isn't. The nausea, the slower pace of titration, the way your appetite changes before your habits do — those are the things that catch people off guard. Wegovy (semaglutide) is a once-weekly prescription injection licensed in the UK for weight management, and a prescriber has to assess whether it's clinically appropriate for you before treatment begins. This page covers the practical and clinical realities that are rarely spelled out in advance, drawn entirely from NHS guidance and the medicine's licensed evidence base.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is the one that sends people off-track earliest. Nausea after starting Wegovy, or after a dose step-up, is expected and documented. It is a direct consequence of how semaglutide works: it slows gastric emptying and acts on hunger-regulating signals in the brain, and your digestive system takes time to recalibrate. The NHS medicines page for semaglutide lists nausea as a common side effect alongside constipation, diarrhoea, vomiting and indigestion, and notes that these effects tend to ease as the body adjusts.
What catches people out is the timing. Nausea often peaks not when you first inject but in the twelve to twenty-four hours that follow, and it can flare again with each new dose level. That is not a sign the medicine is failing or that something has gone wrong. It is the titration schedule doing its job. Small, frequent meals, plain foods, and staying hydrated are the practical tools, but your prescriber is the right person to discuss this with if the symptoms are stopping you from eating adequately or are persisting longer than expected.
Severe or persistent stomach pain that radiates to your back is different, and warrants urgent medical attention: in January 2026, the MHRA issued a Drug Safety Update highlighting acute pancreatitis as a known though infrequent risk with GLP-1 medicines. That update is worth knowing about before you start.
Trial data reported in the STEP 1 study, published in the New England Journal of Medicine, showed an average body-weight reduction of around 15% over 68 weeks in adults taking 2.4mg semaglutide weekly alongside lifestyle support. That is a meaningful figure. It is also a 68-week figure, covering more than a year, measured at a population average.
In practice, the early weeks often feel underwhelming. You are on the starter dose, which is designed to settle your system rather than produce significant weight reduction. Many people see little change in the first month and assume the medicine is not working. It is almost always too soon to judge. The therapeutic effect builds as the dose increases and as the medicine reaches steady state, typically after several months on the maintenance dose. If you want a clearer sense of what progress can realistically look like over time, our Wegovy before and after page brings together what the evidence and real-world experience suggest at each stage.
It is also worth knowing that the trial evidence covers Wegovy used alongside a reduced-calorie diet and increased physical activity. The medicine does not work in isolation. Most people find their appetite falls noticeably, which makes dietary changes more manageable, but the lifestyle component matters. If you want to understand the cost picture before starting, our Wegovy pricing page sets out what a private prescription typically involves in the UK.
Because Wegovy slows the movement of food through the stomach, it can affect how other medicines are absorbed. This is not a reason to panic, but it is a reason to tell your prescriber about every medicine and supplement you take before you start. Your full medication list is part of what a prescriber reviews.
One specific interaction is worth flagging: NHS guidance notes that semaglutide does not carry the same evidence of reduced oral contraceptive pill absorption as tirzepatide does, but this is still an area to raise with your prescriber, especially if you are switching from one GLP-1 to another. Pregnancy is not compatible with Wegovy treatment; the medicine is not recommended for anyone who is pregnant, breastfeeding, or actively trying to conceive.
Timing in another sense also matters. If you are starting treatment around a holiday, a surgical procedure, or any period where your routine will be disrupted, tell your clinical team in advance. Injecting on an unusual day, travelling across time zones, or going under general anaesthetic all have practical implications your prescriber should know about. Our page covering what to do before taking Wegovy is worth going through carefully rather than treating as a formality. Similarly, if you have wondered whether taking Wegovy before bed could help reduce nausea or simply fits your schedule better, our prescribers field that question regularly and the answer is more nuanced than most people expect.
Wegovy is a prescription-only medicine in the UK. That legal status exists because the risk-benefit balance depends on individual clinical factors, weight, medical history, other conditions, other medicines. No legitimate route to it bypasses a prescriber.
At nume, a GPhC-registered Independent Prescriber personally reviews every consultation, reading your answers, your medication history, and the supporting information you provide. Your pen is then dispensed from our GPhC-registered pharmacy (registration number 9012878, verifiable on the GPhC register). That review happens the same day for orders placed before 12pm on a working day, with free next-working-day delivery via DPD once approved. There is no algorithm making the prescribing decision.
A prescriber can also help you think through what to expect, which is, in a lot of cases, the most useful conversation to have before you start. If you are weighing up whether Wegovy is the right route, our weight-loss treatment overview covers both Wegovy and the other licensed options available. When you are ready to talk to a clinician about your own situation, you can start a free consultation at any point.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.